HB 1138: Increasing Access to Contraceptives Act; enact
Última acción: 11 de mayo de 2026 · Effective Date 2027-01-01
House Bill 1138 would let trained Georgia pharmacists dispense birth control pills and give contraceptive shots without a doctor's prescription, and would require insurers and Medicaid to cover larger supplies of contraceptives.
Los resúmenes de abajo son traducciones de resúmenes en inglés escritos por un modelo de IA (claude-sonnet-5) a partir del texto del proyecto de ley; no forman parte de él. El proyecto de ley está en inglés. Cite el texto, no el resumen. El texto almacenado es la versión Enrolled, la más reciente que tiene LegiScan.
El resumen en español de este proyecto de ley se está preparando. Mientras tanto se muestra el resumen en inglés.
En lenguaje claro
Currently, Georgians generally need a prescription from a doctor, nurse practitioner, or physician assistant to get hormonal contraceptives. This bill, called the Increasing Access to Contraceptives Act, creates a new pathway: pharmacists who complete specific training and follow a state-issued protocol could dispense self-administered contraceptives (like the pill) or give injectable contraceptives directly to patients, after a required risk-screening questionnaire and counseling. The bill also changes insurance rules. Health insurance plans that cover prescription drugs would have to cover at least a three-month supply of contraceptives on a patient's first fill and a 12-month supply after that, up to 12 months total per year. Georgia's Medicaid program would have to follow the same supply rules for women enrollees, and reimburse pharmacists for dispensing contraceptives at rates no lower than what physician assistants and nurse practitioners receive. The changes take effect January 1, 2027.
Qué hace el proyecto de ley
- Creates a new Georgia law (O.C.G.A. § 26-4-53) letting trained pharmacists dispense self-administered contraceptives or give injectable contraceptives under a state-issued protocol, without a patient-specific prescription.
- Requires pharmacists to complete an accredited certificate program (12 hours self-study, 8 hours seminar, exam, and hands-on injection training) plus annual continuing education before dispensing.
- Requires pharmacists to screen patients with a risk questionnaire, provide written materials and counseling, and refer patients showing signs of abuse to social services.
- Shields pharmacists who follow the protocol from criminal or civil liability for dispensing contraceptives under this authority.
- Requires private health insurance plans to cover a three-month starter supply and then 12-month supplies of prescription contraceptives, up to 12 months per year.
- Requires Georgia's Medicaid program to provide the same supply amounts to women recipients and to reimburse pharmacists at rates equal to physician assistants and nurse practitioners for the same service.
A quién afecta
Georgia pharmacists and their employers (hospitals and licensed pharmacies), women and other patients seeking contraception, private health insurers operating in Georgia, the Department of Public Health, the Georgia State Board of Pharmacy, and the Georgia Medicaid program serving women recipients.
Por qué importa
Patients could get birth control pills or contraceptive shots directly from a trained pharmacist instead of first seeing a doctor, and could pick up a year's supply at once instead of refilling monthly. Insurers and Medicaid would have to pay for these larger supplies and reimburse pharmacists for the service.
Disposiciones clave
- Section 2 adds O.C.G.A. § 26-4-53, requiring the Department of Public Health and the Georgia State Board of Pharmacy to issue a joint protocol by January 1, 2027 governing training, patient screening, documentation, and reporting for pharmacist-dispensed contraceptives.
- Section 2 sets specific training requirements: 12 hours of self-study, 8 hours of seminar, a written exam, and hands-on injection assessment, plus one hour of annual continuing education.
- Section 2 requires pharmacists to obtain a risk-screening questionnaire from each patient and provide counseling on side effects, backup contraception, and sexually transmitted disease risk before dispensing.
- Section 3 adds O.C.G.A. § 33-24-59.37, requiring insurance plans covering prescription drugs to provide a three-month starter supply and then 12-month supplies of contraceptives, capped at 12 months per year.
- Section 3 bars insurers from denying reimbursement to pharmacists dispensing contraceptives under the new law and requires reimbursement rates equal to those paid to physician assistants and nurse practitioners.
- Section 4 adds O.C.G.A. § 49-4-159.5, applying the same supply rules and pharmacist reimbursement requirement to Georgia's Medicaid program for women recipients.
- Section 4 directs the department to submit any needed Medicaid state plan amendment or waiver request to federal health officials to implement these changes.
- Section 5 sets the effective date as January 1, 2027, applying to insurance policies issued or renewed on or after that date.
Del proyecto de ley
“A pharmacist who dispenses a self-administered contraceptive or administers an injectable contraceptive in accordance with the provisions of this Code section shall not be subject to criminal or civil liability.”
“Every health benefit policy that provides benefits for a prescriptive contraceptive drug shall provide an insured or enrollee with coverage for no less than a three-month supply of the covered prescription at one time the first time that the insured or enrollee obtains the drug”
Cronología del estado
- Effective Date 2027-01-01
- Act 447
- House Date Signed by Governor (Cámara de Representantes)
- House Sent to Governor (Cámara de Representantes)
- House Agreed Senate Amend or Sub (Cámara de Representantes)
- Senate Passed/Adopted By Substitute (Senado)
- Senate Third Read (Senado)
- Senate Taken from Table (Senado)
Mostrar el historial completo (20 acciones)
- Senate Tabled (Senado)
- Senate Taken from Table (Senado)
- Senate Tabled (Senado)
- Senate Read Second Time (Senado)
- Senate Committee Favorably Reported By Substitute (Senado)
- Senate Read and Referred (Senado)
- House Passed/Adopted By Substitute (Cámara de Representantes)
- House Third Readers (Cámara de Representantes)
- House Committee Favorably Reported By Substitute (Cámara de Representantes)
- House Second Readers (Cámara de Representantes)
- House First Readers (Cámara de Representantes)
- House Hopper (Cámara de Representantes)
Patrocinadores
- Beth Camp (R, HD-135)
- Jan Jones (R, HD-047)
- Bethany Ballard (R, HD-147)
- Carmen Rice (R, HD-139)
- Matt Reeves (R, HD-099)
- Gerald Greene (R, HD-154)
- Kay Kirkpatrick (R, SD-032)
Votaciones
- Votación: Cámara de Representantes4 de marzo de 2026
162 a favor, 4 en contra (2 sin votar, 9 ausentes)
- Votación: Senado27 de marzo de 2026
26 a favor, 22 en contra (3 sin votar, 3 ausentes)
- Votación: Senado2 de abril de 2026
29 a favor, 22 en contra (2 sin votar, 1 ausentes)
- Votación: Senado2 de abril de 2026
49 a favor, 1 en contra (3 sin votar, 1 ausentes)
- Votación: Cámara de Representantes2 de abril de 2026
158 a favor, 11 en contra (4 sin votar, 3 ausentes)
Temas
- contraceptive access
- pharmacist prescribing
- health insurance coverage
- Medicaid coverage
- reproductive health